IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 139 filers reported holding IMMUNOGEN INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,777,000 | +99.2% | 348,014 | -5.6% | 0.05% | +133.3% |
| Q3 2019 | $892,000 | -55.1% | 368,757 | -10.9% | 0.02% | -59.6% |
| Q4 2018 | $1,987,000 | +42.1% | 413,953 | +211.5% | 0.05% | +79.3% |
| Q1 2018 | $1,398,000 | -3.9% | 132,882 | -39.6% | 0.03% | -6.5% |
| Q4 2017 | $1,455,000 | +187.5% | 220,145 | +209.3% | 0.03% | +210.0% |
| Q2 2017 | $506,000 | -78.6% | 71,166 | -58.8% | 0.01% | -82.1% |
| Q4 2015 | $2,359,000 | +125.1% | 172,693 | +173.4% | 0.06% | +100.0% |
| Q2 2013 | $1,048,000 | – | 63,160 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |